Quick Look to Guidelines

Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines

Volume 28 · Issue 6 · November 2017 Publish Date: November 15, 2017
Full Text HTML
DOI
Ramazan Idilman
Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey
Idilman, R. (2017). Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines. Turkish Journal of Gastroenterology, 28(6), 518–521. https://doi.org/10.5152/tjg.2017.171017
Full Text Full Text PDF

Abstract

Abstract The morbidity and mortality of hepatitis B virus-related liver disease are linked to the persistence of the hepatitis B virus replication. Viral suppression with antiviral therapy has been shown to provide clinical benefits. Several special groups of patients with hepatitis B virus infection require special attention. In this brief report, based on European Association for the Study of the Liver 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, the current optimal management of special patient groups with hepatitis B virus infection is summarized. Cite this article as: Idilman R. Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines. Turk J Gastroenterol 2017; 28: 518-21.

Most read articles by the same author(s)

1 2 3 4 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 28 · Issue 6 · November 2017
Pages 518-521
History
Published Online November 15, 2017
Copyright
Affiliations
1
Ramazan Idilman
Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey
Cite this Article
Idilman, R. (2017). Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines. Turkish Journal of Gastroenterology, 28(6), 518–521. https://doi.org/10.5152/tjg.2017.171017
Outlines